Oxygenta Pharmaceutical Ltd Financial Statement
*All values are in Rs. Cr
Particulars | Jun 2024 | Mar 2024 | Dec 2023 |
---|---|---|---|
Revenue | 12.64 | 10.81 | 9.18 |
Operating Expense | 14.40 | 12.17 | 11.67 |
Net Profit | -1.36 | 8.02 | -3.78 |
Net Profit Margin | -10.76 | 74.19 | -41.18 |
Earning Per Share | -0.39 | 2.55 | -0.99 |
EBIDTA | -0.30 | 9.25 | -2.73 |
Effective Tax Rate | TBA | TBA | TBA |
Particulars | Jun 2024 |
---|---|
Revenue | 12.64 |
Operating Expense | 14.40 |
Net Profit | -1.36 |
Net Profit Margin | -10.76 |
Earning Per Share | -0.39 |
EBIDTA | -0.30 |
Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
Total Revenue Annual | 39.64 | 30.99 | 60.52 |
Operating Expenses Annual | 49.34 | 38.10 | 59.05 |
Operating Profit Annual | -9.62 | -7.83 | 2.03 |
Interest Annual | 1.59 | 1.49 | 0.92 |
Depreciation | 2.66 | 2.05 | 1.59 |
Net Profit Annual | -3.48 | -11.57 | -0.61 |
Tax Annual | -10.39 | 0.20 | 0.12 |
Particulars | Mar 2024 |
---|---|
Total Revenue Annual | 39.64 |
Operating Expenses Annual | 49.34 |
Operating Profit Annual | -9.62 |
Interest Annual | 1.59 |
Depreciation | 2.66 |
Net Profit Annual | -3.48 |
Tax Annual | -10.39 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
Cash Flow at the Beginning | 0.11 | 0.16 | 0.45 |
Cash Flow from Operations | -13.05 | -1.63 | -1.68 |
Cash Flow from Investing | -4.09 | -9.64 | -4.94 |
Cash Flow from Financing | 17.13 | 11.22 | 6.33 |
Cash Flow at the End | 0.10 | 0.11 | 0.16 |
Particulars | Mar 2024 |
---|---|
Cash Flow at the Beginning | 0.11 |
Cash Flow from Operations | -13.05 |
Cash Flow from Investing | -4.09 |
Cash Flow from Financing | 17.13 |
Cash Flow at the End | 0.10 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
PBDIT Margin (%) | -24.27 | -25.27 | 2.43 |
PBIT Margin (%) | -30.98 | -31.88 | -0.20 |
PBT Margin (%) | -11.50 | -10.49 | 0.01 |
Net PROFIT Margin (%) | -8.78 | -37.33 | -1.01 |
Return On Networth / Equity (%) | TBA | TBA | TBA |
Return On Networth /Employed (%) | TBA | TBA | TBA |
Return On Assets (%) | -10.97 | -48.16 | -3.00 |
Total Debt / Equity (X) | TBA | TBA | TBA |
Asset Turnover Ratio (%) | 1.25 | 1.29 | 2.98 |
Particulars | Mar 2024 |
---|---|
PBDIT Margin (%) | -24.27 |
PBIT Margin (%) | -30.98 |
PBT Margin (%) | -11.50 |
Net PROFIT Margin (%) | -8.78 |
Return On Networth / Equity (%) | TBA |
Return On Networth /Employed (%) | TBA |
Return On Assets (%) | -10.97 |
Total Debt / Equity (X) | TBA |
Asset Turnover Ratio (%) | 1.25 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
Fixed Assets Annual | 29.36 | 27.91 | 19.98 |
Total Current Assets Annual | 24.11 | 25.01 | 9.56 |
Non Current Assets Annual | 39.09 | 29.26 | 21.61 |
Total Shareholders Funds Annual | -20.12 | -46.20 | -34.63 |
Total Assets Annual | 63.19 | 54.26 | 31.18 |
Particulars | Mar 2024 |
---|---|
Fixed Assets Annual | 29.36 |
Total Current Assets Annual | 24.11 |
Non Current Assets Annual | 39.09 |
Total Shareholders Funds Annual | -20.12 |
Total Assets Annual | 63.19 |
No Data Availabe